Global In-Vitro Fertilization (IVF) Market Growth (Status and Outlook) 2024-2030

Global In-Vitro Fertilization (IVF) Market Growth (Status and Outlook) 2024-2030

According to our LPI (LP Information) latest study, the global In-Vitro Fertilization (IVF) market size was valued at US$ 14580 million in 2023. With growing demand in downstream market, the In-Vitro Fertilization (IVF) is forecast to a readjusted size of US$ 21920 million by 2030 with a CAGR of 6.0% during review period.

The research report highlights the growth potential of the global In-Vitro Fertilization (IVF) market. In-Vitro Fertilization (IVF) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of In-Vitro Fertilization (IVF). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the In-Vitro Fertilization (IVF) market.

In vitro fertilization is an assisted reproductive technology (ART), which involves retrieving eggs from a womans ovaries and fertilizing them with sperm outside the body, in vitro.

According to World Bank statistics, the global birth rate in 2021 was about 1.7%. Although the population growth rate had slowed down, with the development of the world economy and the increase of per capita disposable income of residents, the spending power is growing. Therefore, there is still a large room for development in the baby products industry. Improving product quality and tapping the value of a single customer will become the drivers for the growth of the infant and child industry. Refinement and diversification are the core characteristics of the consumer demand. China has a large population base, and even if the population growth rate slows down, there will still be a demographic dividend. The State Council in 2022 proposes to "Guide market players to produce safer and healthier domestic infant products". According to the National Bureau of Statistics, China's birth rate in 2022 was 6.77%, and the birth population was 9.56 million. According to the results of the seventh national census in 2021, the number of infants and young children aged 0-6 in China reached 140 million, of which the number of infants and young children aged 3-6 exceeded 70 million. The huge population size has brewed a market demand with huge potential, and the children's consumption market has risen rapidly. Chinese families spend a lot on childcare, with the average cost of childcare ranking second in the world. The survey data released by China Research Center for Children's Industry shows that in 80% of families in China, children's expenditures account for 30% to 50% of household expenditures, and the average annual consumption of children in families is ¥17,000 to 25,500. According to data from the Yuwa Population Research, the national average cost of raising a child (the cost of raising a child to the age of 18) is ¥485,218. From the perspective of specific stages, the largest proportion is the cost of raising children aged 6-14, accounting for about 45%. The cost during pregnancy, the cost of childbirth and confinement, and the cost of raising babies aged 0-2 accounted for 2.06%, 2.09% and 13.33% separately.

Key Features:

The report on In-Vitro Fertilization (IVF) market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the In-Vitro Fertilization (IVF) market. It may include historical data, market segmentation by Type (e.g., Culture Media, Disposable Devices), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the In-Vitro Fertilization (IVF) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the In-Vitro Fertilization (IVF) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the In-Vitro Fertilization (IVF) industry. This include advancements in In-Vitro Fertilization (IVF) technology, In-Vitro Fertilization (IVF) new entrants, In-Vitro Fertilization (IVF) new investment, and other innovations that are shaping the future of In-Vitro Fertilization (IVF).

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the In-Vitro Fertilization (IVF) market. It includes factors influencing customer ' purchasing decisions, preferences for In-Vitro Fertilization (IVF) product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the In-Vitro Fertilization (IVF) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting In-Vitro Fertilization (IVF) market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the In-Vitro Fertilization (IVF) market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the In-Vitro Fertilization (IVF) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the In-Vitro Fertilization (IVF) market.

Market Segmentation:

In-Vitro Fertilization (IVF) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
Culture Media
Disposable Devices
Capital Equipment

Segmentation by application
Fertility Clinics
Hospitals
Surgical Centers
Clinical Research Institutes

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
OvaScience
EMD Serono Inc.
Vitrolife AB
Irvine Scientific
Cook Medical Inc.
Cooper Surgical Inc.
Genea Biomedx
Thermo Fisher Scientific Inc.
Progyny Inc.
Boston IVF

Please note: The report will take approximately 2 business days to prepare and deliver.